Tag: Obesity drugs
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...
Pfizer’s Activist Investor, Medicare Costs for Obesity Drugs, and More: Pharmalittle Update
Good day to all our readers, we hope you are having a productive week so far. As we look forward to the weekend, let's stay focused and keep pushing forward. Today, we suggest enjoying...
What Happens When You Stop Taking New Obesity Drugs?
Susana Parks, a 60-year-old from Bend, Oregon, was thrilled to have lost 40 pounds while taking Eli Lilly's obesity drug, Zepbound. However, now that she has reached her goal weight, she is faced with...